Treatment Trials

1 Clinical Trials for Various Conditions

Focus your search

      RECRUITING
      Guanfacine for Hyperactivity in Children with Down Syndrome (HYPEbeGONE_DS)
      Description

      The purpose of this study is to determine efficacy of guanfacine immediate release (GIR) for the treatment of hyperactivity/impulsivity and inattention in children 6-12 years of age with Down syndrome (DS) after 8 weeks of treatment.

      Conditions
      Hyperactivity in Children with Down SyndromeImpulsivity in Children with Down Syndrome
      Talk to us